The global cell cryopreservation market revenue was around US$ 12.5 billion in 2023 and is estimated to reach US$ 76.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.2% during the forecast period from 2024 to 2032.
Cryopreservation is the process of freezing tissues and cells at low temperatures to preserve biological material's viability, prevent ice crystal formation, and maintain metabolic inertness. Ice crystals are microscopic ice crystals that form at very low temperatures. These have the potential to damage a cell's or tissue's cell membrane and cause the cell to die. Cells are cryopreserved to reduce genetic alteration and prevent loss from contamination. Cryopreservation is a technique that can be used to preserve a wide range of biological materials, including tissue cells, established cell lines, small multicellular organisms, complex cellular structures like proteins and nucleic acids, and embryos. Different types of medium or serum are used to freeze cells.
Factors Influencing Market Growth
- There is an increase in the number of women choosing to undergo egg-freezing cycles. This is fueling the demand for reliable and effective cell cryopreservation techniques, ultimately propelling market growth.
- The increase in R&D activities for stem cells will also increase the demand for cell cryopreservation, thus expanding the market.
- The rise in the number of biobanks and the surge in demand for personalized medicines have increased the demand for cell cryopreservation, thus expanding the market.
- The availability of alternative techniques for cell cryopreservation may hamper market growth.
Impact of COVID-19
COVID-19 positively impacted the market. More focus was placed on the research and development of cures and vaccines, necessitating the storage and preservation of cells for future use. This led to an increase in the demand for products and services associated with cell cryopreservation. The need to prepare for unanticipated medical emergencies was underscored by the pandemic, which further propelled the growth of the cell cryopreservation market. Due to the need to preserve biological material and ongoing research, the market for cell cryopreservation is expected to grow steadily in the post-pandemic era.
Regional Insights
North America dominated the market in 2023. This is because of the abundance of major cryopreservation product manufacturers, developed economies, sophisticated medical infrastructure, notable players, and well-established supply chains. In addition, the biopharmaceutical industry is in a race to develop novel and effective treatments due to the rising prevalence of illnesses and the growing elderly population. Due to this, there is now a greater need for cell cryopreservation, which is expected to continue to be profitable in the years to come.
Leading Competitors
- BioLife Solutions, Inc.
- Danaher Corporation
- PromoCell GmbH
- Merck Group KGaA
- Sartorius AG
- HiMedia Laboratories
- Thermo Fisher Scientific, Inc.
- Eppendorf Corporate
- Lonza
- Creative Biolabs
- Other Prominent Players
Segmentation Analysis
The global cell cryopreservation market segmentation focuses on type, application, end-user, and region.
Segmentation based on Type
- Cryopreservation media
- Ethylene glycol
- Dimethyl sulfoxide
- Glycerol
- Others
- Equipment
- Freezers
- Liquid nitrogen supply tanks
- Others
Segmentation based on Application
- Stem cells
- Oocytes cells
- Sperm cells
- Others
Segmentation based on End-User
- Pharmaceutical and biotechnology company
- Research institute
- Others
Segmentation based on Region
- North America
- The U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest Of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa